Results: Responses were received from 49/57 (86%) UK units and 103/115 (90%) Italian units. NRS was started in the delivery room by 61% of UK units and 85% of Italian units. In neonatal intensive care units, 33% of UK units used nasal high-flow therapy (HFT) as primary support, compared to 3% in Italy. Nasal continuous positive airway pressure (CPAP) was used in 57% of UK units and 90% of Italian units. The commonest starting flow rate on nasal HFT for term and preterm infants was 6 L/min in the UK, while Italian units mainly used this flow for term infants. In the UK, 67% of units decreased nasal HFT by 1 L/min per day. In Italy, infants on nasal CPAP were weaned by 1 cm H 2 O per day in 39% of units.
INTRODUCTION
The care of premature infants has improved significantly over the last decade, leading to decreased mortality from respiratory failure and a reduction in long-term sequelae (1) . Mechanical ventilation has been related to the development of bronchopulmonary dysplasia and associated with adverse neonatal outcomes, especially when it has been provided for prolonged periods of time (2) . Several studies have shown the benefits of primary non-invasive respiratory support (NRS) and nasal continuous positive pressure (CPAP) has been recognised as an way of providing NRS for preterm babies from birth onwards (3) . Nasal high-flow therapy (HFT) has been successfully used to provide NRS in a large range of clinical scenarios and has gained significant popularity (4, 5) . Surveys published in 2012 and 2013 reported that nasal HFT was becoming popular worldwide (6, 7) .
While it is widely accepted that further studies are needed on the use of nasal HFT treatment for respiratory failure, a particular concern is its primary use in very preterm infants with a gestational age of less than 28 weeks (8) . The main perception is that nasal HFT is a better tolerated form of NRS than nasal CPAP. An updated Cochrane review published in 2016 concluded that nasal HFT caused significantly less nasal trauma was more comfortable for patients and resulted in better infant feeding and easier bonding than nasal CPAP (9) .
Only a small number of randomised controlled trials have so far investigated the use of nasal HFT for very preterm infants from birth, starting in the delivery room (10) . 
Key Notes
This study explored how non-invasive respiratory support (NRS) was provided by 103 neonatal units in Italy and 49 in the UK. An NRS questionnaire was sent to tertiary neonatal centres, identified by national societies, from November 2015 to May 2016. The way that NRS was managed for very preterm infants differed between the UK and Italy, reflecting a lack of evidence on optimal NRS and the use of local protocols.
However, encouraging data have been published regarding its use in late preterm infants (11) .
Faced with on-going controversy in the neonatal community about treating very preterm infants with respiratory failure with nasal HFT, we carried surveyed tertiary neonatal intensive care units (NICUs) in the UK and Italy to compare current NRS techniques in two European countries.
METHODS
We approached 57 tertiary NICUs in the UK and 115 NICUs in Italy and asked them to take part in our online survey, which was created using FreeOnlineSurveys.com. The questionnaire comprised 16 multiple-choice questions covering all methods of NRS used as primary support for preterm and term babies. The accompanying email included a brief description of the purpose of the survey and the unit's consent to participate was provided by completing the survey.
In both countries, the questionnaire was sent to the chief neonatologist in the first instance. If they did not reply then we emailed one of the unit's consultants. To maximise the responses to the survey, we sent up to four reminders and non-responders were contacted by phone. We finally received responses from 49 of the UK units and 103 of the Italians unit.
Statistical analysis
The data were analysed using SPSS Statistics for Windows, version 23.0 (IBM Corp, Armonk, NY, USA). The significance of the differences between the responses from the two countries was calculated using the chi-square test. A p value of less than 0.05 was considered statistically significant.
RESULTS
We contacted 172 NICUs in the UK and Italy and 49/57 UK units (86%) and 103/115 Italian units (90%) took part in the survey. All the units who took part answered all the questions summarised in these results. In the UK, 69% of the units started NRS in the delivery room, 4% with nasal HFT and 65% with nasal CPAP. In Italy, 86% of the units started NRS in the delivery room, 1% with nasal HFT and 85% with nasal CPAP (p < 0.001).
In both countries, nasal CPAP was the most widely used NRS application, used by 57% of the units in the UK and 90% in Italy (p < 0.001). Nasal HFT was used in 33% of the UK units and 3% of Italian units (p =< 0.001). When nasal HFT was used, the most popular devices were the Precision Flow Plus (Vapotherm, Exeter, NH, USA), used by 57% of the UK units and 46% of the Italian units, and the Optiflow (Fisher and Paykel Healthcare, Auckland, New Zealand) used by 32% and 25%, respectively. In the UK, 67% of the units had local protocols for using and weaning off nasal HFT: 6% just for administration and 61% for both administration and weaning. The other 33% did not use guidelines. In Italy, 49% of the units had guidelines for nasal HFT: 16% just for administration and 33% for both administration and weaning (p = 0.004). The other 51% did not use guidelines.
The starting flow rate for nasal HFT in the two countries is described in Table 1 .
With regard to the starting positive pressure value on nasal CPAP, 45% of the UK NICUs started with 6 cm H 2 O, 33% with 5 cm H 2 O and 22% with less than 6 cm H 2 O. None of the UK units that were surveyed used nasal CPAP levels of less than 4 cm H 2 O. In Italy, 58% started with 5 cm H 2 O, 29% with 6 cm H 2 O and 10% with 4 cm water. Only 3% of the Italian units used nasal CPAP levels of less than 6 cm H 2 O (p < 0.001).
We found that 96% of the UK units did not use high-flow breaks during nasal CPAP in the weaning phase and 4% of the units said they did not use any nasal CPAP. In Italy, 19% of the units used breaks with nasal HFT during nasal CPAP treatment, 80% said they did not use breaks and 1% did not use nasal CPAP (p = 0.002).
The units were asked how they would handle the nasal HFT weaning of a clinically stable baby with a fraction of inspired oxygen of less than 0.4 and the results are described in Figure 1 .
With regard to other forms of NRS, nasal high-frequency oscillatory ventilation was used in just one unit (2%) in the UK and in 14% of the Italian units (p = 0.026).
Less invasive surfactant administration (LISA) or minimally invasive surfactant administration (MIST) were in use in 16% of the UK centres in the UK and 41% of the Italian centres at the time of our survey and most of these employed nasal CPAP (p = 0.008).
Nasal intermittent positive pressure ventilation (IPPV) was used as the first-line NRS in 12% of the UK units and 12% of the Italian units and 43% of the UK units and 47% of the Italian units used nasal IPPV as a rescue treatment if nasal CPAP or nasal HFT were not tolerated. We noted that 45% of the UK units and 40% of the Italian units did not use nasal IPPV (p = 0.736).
In the UK, 61% of the units started NRS without intubation and surfactant administration in infants born at less than 27 weeks of gestational age, while the Italian figure was 85% (p < 0.05). This approach was used by 39% of UK units and 36% of Italian units when babies were born at 23-25 weeks and 61% and 64%, respectively, when they were born 25-27 weeks (Fig. 2) .
DISCUSSION
This survey showed significant differences, and also some similarities, regarding the use of NRS for preterm infants in Italy and the UK. The management of very preterm infants at, or shortly after, birth differed substantially between the two countries and it seemed that a different approach in the delivery room influenced the on-going use of NRS in the NICU.
To our knowledge, this was the first survey to explore the primary mode of NRS used by NICUs in two large healthcare systems, by carrying out national surveys in the UK and Italy. With regard to delivery room management, our data suggest that the approach to very preterm infants with RDS was different in the two countries. It was interesting to find that the use of NRS, instead of routine intubation, in infants of less than 27 weeks of gestational age, was more common in Italy than in the UK. We speculate that this could be explained by differences in the seniority of the physicians attending deliveries in the two countries. In Italy, all preterm deliveries are attended by the most senior consultant neonatologist available. Hence, it is reasonable to assume that a less invasive approach is adopted more easily when individual expertise is higher. This hypothesis warrants further investigation.
In both countries, nasal CPAP was the most used NRS mode in the NICUs. This result was in keeping with published data regarding the delivery room management in German, Austrian and Swiss neonatal units, where nasal CPAP tended to be the predominant form of NRS from birth. However, the authors did not include nasal HFT in their questionnaire when they carried out their study (12) . This may, indeed, be changing now. While most (90%) of the responding centres in Italy used nasal CPAP as a primary mode, 33% of the UK units favoured of nasal HFT. These findings were consistent with a UK report by Ojha et al. (6) and data from Australia and New Zealand (7).
In our study, only a few NICUs used nasal HFT in the delivery room. One UK pilot study showed that the early use of nasal HFT in the delivery room was feasible and produced encouraging results (10) . However, the study centre had used nasal HFT for a decade and this might not be applicable to another unit with exclusive nasal CPAP use.
There have not been any surveys that have explicitly described the use of NRS in Italy. A survey by Dani et al. (13) reported on strategies for respiratory support in Italian NICUs, but excluded nasal HFT. We speculate that nasal CPAP is still very popular in Italy since it has been successfully used for several decades and some of the most important studies on the use of nasal CPAP for respiratory failure management have included Italian NICUs among their participants (14, 15) . The high variations in different units, especially with regarding weaning, were probably due to the lack of strong evidence for or against either form of NRS, nasal CPAP or nasal HFT, as reported in a Cochrane review in 2016 (9) . However, guidelines and consensus statements were published in 2016 and 2017 after this study was carried out (4, 16) .
The nasal HFT flows used for preterm and term babies differed slightly between the two countries, in particular in relation to gestational age. The starting flow rates were the same in term babies, but were lower in Italy for preterm babies. This more cautious approach could be explained by the fact that the high pressure in the airways may be potentially harmful (17) . Wilkinson et al. (18) showed that the pressure generated by nasal HFT was inversely proportional to the weight of the neonate and influenced by the volume of the nasopharyngeal space.
The generation of distending pressure is not the main mechanism of action of nasal HFT, but it is an important factor that makes it a potential alternative to nasal CPAP (19) . To date, several mathematical formulas have been proposed to establish equivalence between the flow delivered by nasal HFT and the pressure generated by nasal CPAP (18, 20) . However, they were not generalisable and their use is not currently recommended in clinical settings (4) . It has been shown that the pressure delivered by nasal HFT is equal to, or lower than, the one provided by CPAP. Therefore, increases in the flow lead to an increase in the pressure generated (21) .
With respect to use of nasal CPAP in our survey, 5-6 cm water were the commonest continuous distending pressure levels to start NRS. These findings were in keeping with results from NICUs in Germany, Austria and Switzerland (12) . In both of the countries in our study, the neonatologists' choice of nasal CPAP levels, both in the delivery room and in the NICU, were consistent with the latest recommendations for respiratory distress syndrome management (22, 23) .
To date, there has been little evidence about weaning from nasal CPAP with nasal HFT (24) . Abdel Hady et al. (25) , investigated infants who were less than 28 weeks of gestational age and supported by nasal CPAP and nasal HFT. They found a significant increase in the duration of oxygen requirements and respiratory support in the nasal HFT group, but no significant difference in the success of weaning between the two groups. However, Badiee et al. (26) showed a significant reduction of oxygen dependency and duration of hospitalisation in babies of less than 28 weeks of gestational age randomised to nasal HFT once they were stable on nasal CPAP. The majority of the units in both countries used 0.5-1 L/min every 24 hours and only a few NICUs chose a more rapid approach to weaning.
We further investigated the relationship between NRS and surfactant use for RDS management. At present, the use of nasal CPAP immediately after birth, followed by elective administration of surfactant is indicated as an alternative to routine intubation (22) . However, the efficacy of NRS is closely related to gestational age. One study reported that about 50% of the very low birth weight infants who were initially put on nasal CPAP needed subsequent intubation and mechanical ventilation (17) . Two surveys published in 2017 showed the popularity of LISA or minimally invasive surfactant therapy in other parts of Europe, such as Germany and Northern Europe, where they are increasingly being used (27, 28) . At the time of our study, the use of LISA or MIST for surfactant administration was more widespread in Italy than in the UK (41% vs. 16%). This was mostly in combination with nasal CPAP, given the lack of evidence regarding the use of the LISA or MIST techniques during nasal HFT.
The strength of our survey was the high response rate, which was comparable to other surveys on neonatal ventilation practice (6, 7, 13) . Our survey also had several limitations. Firstly, this was a questionnaire study and thereby retrospective in nature. Secondly, we chose to only survey tertiary NICUs and that means that we did not assess the use of nasal HFT among level one and level two units, which would be predominantly treating infants who were less than 28 weeks of gestational age. Thirdly, we did not investigate reasons for choosing one form of NRS over another. This can be considered a limitation since the impact of nurses and parents' perception may influence the choice of NRS strategy (29) . According to Roberts et al. and Klingenberg et al., nurses perceive nasal HFT to be superior for facilitating a minimal-handling strategy and parents prefer nasal HFT over nasal CPAP for bonding (29, 30) .
CONCLUSION
We found significant differences between the UK and Italy with regard to NRS strategies in very preterm infants at, and shortly after, birth. Our observations may reflect different interpretations of the current state of evidence regarding safety and efficacy of different forms of NRS, in particular nasal HFT. At the time of study, there appeared to be a lack of published consensus statements or advice regarding the application and weaning of nasal HFT. Further trials investigating the most appropriate form of NRS are warranted.
